Frontlight ResearchEarly access
Trial site
LAC & USC Medical Center
- 4running trials
- 1closed trial
The trials here
What the 5 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)2 trials
- Hepatitis B2 trials
- Hepatitis C2 trials
- Liver cirrhosis2 trials
- Acute myeloid leukaemia1 trial
- Bladder cancer1 trial
- Childhood cancers1 trial
- Colorectal cancer1 trial
- Diffuse large B-cell lymphoma1 trial
- Multiple myeloma1 trial
- Prostate cancer1 trial
- Phase
- Phase 22 trials
- Phase 11 trial
- Phase 31 trial
- Status
- Active, not recruiting3 trials
- Recruiting1 trial
- Terminated1 trial
- Lead sponsor
- Pfizer2 trials
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)1 trial
- Northwestern University1 trial
- University of Southern California1 trial
Running trials
Recruiting
Liver Cirrhosis Network Rosuvastatin Efficacy and Safety for Cirrhosis in the United States
Active, not recruiting
Active, not recruiting
Active, not recruiting
Multicohort Phase II Trial of sEphB4-HSA+Pembrolizumab in Solid Tumors
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)1 recruiting
- Hepatitis B1 recruiting
- Hepatitis C1 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Site data: ClinicalTrials.govUpdated 12 Nov 2026